Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China · Delayed Price · Currency is CNY 49.80
+3.18 (6.82%)
Sep 30, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Revenue
Hangzhou Alltest Biotech had revenue of 196.77M CNY in the quarter ending June 30, 2026, a decrease of -11.11%. This brings the company's revenue in the last twelve months to 867.64M, down -3.59% year-over-year. In the year 2025, Hangzhou Alltest Biotech had annual revenue of 905.34M with 4.47% growth.
Revenue (ttm)
867.64M
Revenue Growth
-3.59%
P/S Ratio
4.35
Revenue / Employee
903.79K
Employees
960
Market Cap
3.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 905.34M | 38.76M | 4.47% |
| Dec 31, 2024 | 866.58M | 111.89M | 14.83% |
| Dec 31, 2023 | 754.70M | -2.63B | -77.73% |
| Dec 31, 2022 | 3.39B | 1.52B | 80.88% |
| Dec 31, 2021 | 1.87B | 737.87M | 64.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.